NUVB logo

Nuvation Bio (NUVB)

Profile

Full Name

Nuvation Bio Inc.

Ticker Symbol

NUVB

Exchange

NYSE

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 26, 2020

Indexes

Not included

Website

http://www.nuvationbio.com

Employees

220

Key Details

Price

$1.99(-1.49%)

Market cap

$673.97M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.87M

Annual EPS

-$2.11(-502.86% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.99
NUVB price is $1.99

30-Day Relative Volume

1.13
NUVB 30-day relative volume is 1.13

Price Performance

Price Today change

-1.49%
NUVB price is down -1.49% today

Price YTD change

-25.19%
NUVB price is down -25.19% since January 1st

Price 1-year change

-30.9%
NUVB price is down -30.9% year-on-year

Price 3-year change

-63.88%
NUVB price is down -63.88% over the past 3 years

Price Range

Price All-time high

$15.23
NUVB price is currently -86.93% below its historical high of $15.23

Price 3-year low

$0.95
NUVB price is currently +109.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$673.97M
NUVB market capitalization is $673.97 million

Market cap 3-year change

-43.92%
NUVB market capitalization is down -43.92% over the past 3 years

Market cap All-time high

$3.17B
NUVB market capitalization is currently -78.75% below its historical high of $3.17 billion

Market cap sector rank

72.78%
NUVB market capitalization is higher than 72.78% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+37.27%
NUVB shares outstanding is up +37.27% year-on-year

Shares Outstanding 3-Year Change

+55.27%
NUVB shares outstanding is up +55.27% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.19
NUVB beta is 1.19

200-day SMA

$2.60
NUVB price is currently -23.52% below its 200-day simple moving average

50-day SMA

$2.03
NUVB price is currently -2.05% below its 50-day simple moving average

RSI

55.47
NUVB 14-day relative strength index is 55.47

Volume

1.13
NUVB 30-day relative volume is 1.13

ATR

$0.19
NUVB average true range is $0.19

10-day Historical Volatility

108.58%
NUVB 10-day historical volatility is 108.58%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$7.87M
NUVB annual revenue is $7.87 million

Revenue Analysts estimate

$13.56M
NUVB annual revenue is currently -41.94% lower than the consensus analysts' forecast

Revenue 1-year change

-
NUVB annual revenue 1-year change is unknown

Revenue Sector rank

25.2%
NUVB annual revenue is higher than 25.2% of companies in Healthcare sector

EPS

EPS

-$2.11
NUVB annual earnings per share is -$2.11

EPS Analysts estimate

-$0.57
NUVB annual earnings per share is currently +270.18% higher than the consensus analysts' forecast

EPS 1-year change

-502.86%
NUVB annual earnings per share is down -502.86% year-on-year

EPS Sector rank

37.72%
NUVB annual earnings per share is higher than 37.72% of companies in Healthcare sector

Profit

Gross profit

$795.00K
NUVB annual gross profit is $795.00 thousand

Gross margin

10.10%
NUVB annual gross profit margin is 10.10%

Operating profit

-$592.63M
NUVB annual operating income is -$592.63 million

Operating margin

-7527.33%
NUVB annual operating profit margin is -7527.33%

Net income

-$567.94M
NUVB annual net profit is -$567.94 million

Net margin

-7213.76%
NUVB annual net profit margin is -7213.76%

Expenses

Total expenses

$600.50M
NUVB annual total expenses is $600.50 million

Operating expenses

$593.42M
NUVB annual total operating expenses is $593.42 million

Cost of goods sold

$7.08M
NUVB annual cost of goods sold is $7.08 million

Selling, general & administrative expenses

$69.23M
NUVB annual SGA is $69.23 million

Depreciation and amortization

$683.00K
NUVB annual depreciation & amortization is $683.00 thousand

Interest expense

$341.00K
NUVB annual interest expense is $341.00 thousand

Income tax

$0.00
NUVB annual income tax is $0.00

EBIT & EBITDA

EBIT

-$567.60M
NUVB annual earnings before interest & taxes is -$567.60 million

EBITDA

-$566.91M
NUVB annual EBITDA is -$566.91 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$540.63M
NUVB annual total assets is $540.63 million

Non current assets

$14.37M
NUVB annual long term assets is $14.37 million

Current assets

$526.25M
NUVB annual total current assets is $526.25 million

Cash and cash equivalents

$35.72M
NUVB annual cash & cash equivalents is $35.72 million

Accounts receivable

$12.72M
NUVB annual accounts receivable is $12.72 million

Inventory

-
NUVB annual inventory value is unknown

Liabilities

Total liabilities

$76.84M
NUVB annual total liabilities is $76.84 million

Long term liabilities

$18.59M
NUVB annual total long term liabilities is $18.59 million

Current liabilities

$58.24M
NUVB annual total current liabilities is $58.24 million

Accounts payable

$6.35M
NUVB annual accounts payable is $6.35 million

Debt

Total debt

$8.91M
NUVB annual total debt is $8.91 million

Total debt 1-year change

+122.49%
NUVB annual total debt is up +122.49% year-on-year

Long term debt

$969.00K
NUVB annual long term debt is $969.00 thousand

Short term debt

$7.95M
NUVB annual short term debt is $7.95 million

Equity & Capital

Shareholders equity

$463.79M
NUVB annual stockholders equity is $463.79 million

Book value

$463.79M
NUVB annual book value is $463.79 million

Retained earnings

-$910.74M
NUVB annual retained earnings is -$910.74 million

Working capital

$468.01M
NUVB annual working capital is $468.01 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$130.41M
NUVB annual cash flow from operations is -$130.41 million

Cash from operations 1-year change

-91.79%
NUVB annual cash flow from operations is down -91.79% year-on-year

Cash from investing

$122.70M
NUVB annual cash flow from investing activities is $122.70 million

Cash from investing 1-year change

+1275.44%
NUVB annual cash flow from investing activities is up +1275.44% year-on-year

Cash from financing

$331.00K
NUVB annual cash flow from financing activities is $331.00 thousand

Cash from financing 1-year change

-47.29%
NUVB annual cash flow from financing activities is down -47.29% year-on-year

CAPEX

CAPEX

$162.00K
NUVB annual capital expenditures is $162.00 thousand

CAPEX 1-year change

-
NUVB annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$130.57M
NUVB annual free cash flow is -$130.57 million

Free cash flow 1-year change

-91.83%
NUVB annual free cash flow is down -91.83% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

10.10%
NUVB annual gross profit margin is 10.10%

Operating margin

-7527.33%
NUVB annual operating profit margin is -7527.33%

Net margin

-7213.76%
NUVB annual net profit margin is -7213.76%

ROA & ROE

ROA

-105.05%
NUVB annual return on assets is -105.05%

ROE

-106.27%
NUVB annual return on equity is -106.27%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NUVB price to earnings ratio value is unknown

PE ratio Sector rank

-
NUVB price to earnings ratio is unknown

PB Ratio

PB ratio

1.45
NUVB price to book ratio is 1.45

PB ratio Sector rank

53.99%
NUVB price to book ratio is higher than 53.99% of companies in Healthcare sector

PS Ratio

PS ratio

85.61
NUVB price to sales ratio is 85.61

PS ratio Sector rank

94.49%
NUVB price to sales ratio is higher than 94.49% of companies in Healthcare sector

Enterprise value

Enterprise value

$647.16M
NUVB enterprise value is $647.16 million

Enterprise value Sector rank

71.9%
NUVB enterprise value is higher than 71.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.13
NUVB EV/EBITDA is -1.13

EV/EBITDA Sector rank

41.22%
NUVB EV/EBITDA is higher than 41.22% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.04
NUVB annual current ratio is 9.04

Quick ratio

-
NUVB annual quick ratio value is unknown

Leverage

Debt to equity

0.01
NUVB annual debt to equity ratio is 0.01

Interest coverage ratio

-1664.51
NUVB annual interest coverage ratio is -1664.51

Risk & Stability

Piotroski F-Score

-
NUVB piotroski f-score value is unknown

Altman Z-Score

0.49
NUVB altman z-score is 0.49

Analyst ratings

Recent major analysts updates

Mar 12, 25 Jones Trading
Buy
Mar 10, 25 HC Wainwright & Co.
Buy
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 7, 25 RBC Capital
Outperform
Jan 6, 25 HC Wainwright & Co.
Buy
Nov 7, 24 RBC Capital
Outperform
Oct 22, 24 Wedbush
Outperform
Sep 16, 24 HC Wainwright & Co.
Buy
Sep 11, 24 Wedbush
Outperform

Institutional Ownership

Similar stocks

SLP logo
Simulations Plus (SLP)
PHVS logo
Pharvaris NV (PHVS)
EMBC logo
Embecta (EMBC)
IRMD logo
IRadimed (IRMD)
WEAV logo
Weave Communications (WEAV)
CRON logo
Cronos (CRON)
AXGN logo
AxoGen (AXGN)
EOLS logo
Evolus (EOLS)
NUTX logo
Nutex Health (NUTX)
  • What is the ticker symbol for Nuvation Bio?
  • Does Nuvation Bio pay dividends?
  • What sector is Nuvation Bio in?
  • What industry is Nuvation Bio in?
  • What country is Nuvation Bio based in?
  • When did Nuvation Bio go public?
  • Is Nuvation Bio in the S&P 500?
  • Is Nuvation Bio in the NASDAQ 100?
  • Is Nuvation Bio in the Dow Jones?
  • When was Nuvation Bio's last earnings report?
  • When does Nuvation Bio report earnings?
  • Should I buy Nuvation Bio stock now?

What is the ticker symbol for Nuvation Bio?

The ticker symbol for Nuvation Bio is NYSE:NUVB

Does Nuvation Bio pay dividends?

No, Nuvation Bio does not pay dividends

What sector is Nuvation Bio in?

Nuvation Bio is in the Healthcare sector

What industry is Nuvation Bio in?

Nuvation Bio is in the Biotechnology industry

What country is Nuvation Bio based in?

Nuvation Bio is headquartered in United States

When did Nuvation Bio go public?

Nuvation Bio's initial public offering (IPO) was on August 26, 2020

Is Nuvation Bio in the S&P 500?

No, Nuvation Bio is not included in the S&P 500 index

Is Nuvation Bio in the NASDAQ 100?

No, Nuvation Bio is not included in the NASDAQ 100 index

Is Nuvation Bio in the Dow Jones?

No, Nuvation Bio is not included in the Dow Jones index

When was Nuvation Bio's last earnings report?

Nuvation Bio's most recent earnings report was on Mar 6, 2025

When does Nuvation Bio report earnings?

The next expected earnings date for Nuvation Bio is May 14, 2025

Should I buy Nuvation Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page